Catherine Gaudin

Catherine Gaudin has over 20 years of experience in clinical research, particularly in oncology. Currently, they serve as the Pilote de programme stratégique for the CANcer TOxicity initiative at Unicancer, where they leverage real-world evidence and machine learning to enhance clinical data analysis. Previously, Catherine held positions as a Senior Global Study Manager at Sanofi and a Statistician at PHOENIX Pharma France, overseeing statistical activities and operational planning for various clinical trials. Their expertise includes managing the complexities of phase 1 to 3 clinical trials and leading statistical analyses across multiple therapeutic areas.